---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-074952"
form_type: "8-K"
ticker: "HRTX"
cik: "0000818033"
company_name: "HERON THERAPEUTICS, INC. /DE/"
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T04:00:28.553278+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Heron shareholders approve increase in authorized shares to 400M and equity plan share expansion

## Summary
- Authorized common stock increased by 175M shares from 225M to 400M; effective June 13, 2024.
- 2007 Plan shares increased by 7.5M (from 39.19M to 46.69M) and ESPP shares by 1.2M (from 2.225M to 3.425M).
- All six director nominees elected with ~87M votes for each; auditor ratified with ~114M votes for.
- Say-on-pay advisory vote passed with 72.7M for vs 14.4M against; broker non-votes of 29.2M.

## SEC filing metadata
- accession: 0000950170-24-074952
- form_type: 8-K
- ticker: HRTX
- cik: 0000818033
- company_name: HERON THERAPEUTICS, INC. /DE/
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818033/000095017024074952/0000950170-24-074952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818033/000095017024074952/hrtx-20240613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-074952
- JSON: https://secwatch.observer/filing/0000950170-24-074952.json
- Plain text: https://secwatch.observer/filing/0000950170-24-074952.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.